This study also reported on the reduction of symptoms of heart failure as well as improvement in physical limitations and exercise function due to the weight loss achieved by patients, suggesting that obesity-related comorbidities such as heart failure would benefit from a GLP-1 RA. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.